 | | | | |
| |  | |  | | |
| |
 |
| PRIME NEWS | |
|
 |
|
|
Developing a strong pharmaceutical industry is a key issue in Korea. So much so, that, Battelle-Korea, the non-profit independent research and development organization and YuYu, the pharmaceutical company intend to collaborate
|
|
|
|
|
|
|
|
|
The Korean FDA (KFDA) has granted marketing approval for US-based Abraxis BioScience's Abraxane to treat breast cancer after failure of standard chemotherapy
|
|
|
|
|
|
|
| | | 
BioSpectrum Korea brings to you the latest news and information on Korea medical technology, Korea biotech industry, Korea medical devices and Korean pharmaceutical trends.
| | | | |  | |  | | |
|
|
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
|
Korea: the new IT-BT convergence hub
|
|
| South Korea is making an all-out attempt to power its economy with the IT-BT convergence. Leveraging on its superior IT technology the country is looking at creating synergistic combination of biotechnology, information technology and nanotechnology |
|
|
|
|
|
Korea promotes biotech industry
|
|
| BioSpectrum provides a peek into the booming biotech industry in the Asia Pacific region by profiling the biotech parks from various countries in the region. Korea offers specialized biotech parks that boast of an array of services |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Korean companies ready to take-off
|
|
| Youngguk Cho has over 20 years of experience in the biotechnology industry. Currently, he works as Vice President of Korea Integrated Services (KIS) |
|
|
|
|
|
Mr Kim to head GE Healthcare Korea
|
|
| GE Healthcare has promoted and appointed Mr W S Kim, formerly the service manager of GE Healthcare Korea, as the new President of GE Healthcare Korea |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Abraxis to market Abraxane in Korea
|
|
| The Korean FDA (KFDA) has granted marketing approval for US-based Abraxis BioScience's Abraxane to treat breast cancer after failure of standard chemotherapy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
F&S: South Korea bullish on pharma
|
|
| According to Frost & Sullivan, the South Korean Healthcare Industry could witness tremendous growth in the next five to 10 years, as the Government has promised to increase its healthcare and R&D expenditure
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
